Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
about
Polyethylene glycol-polylactic acid nanoparticles modified with cysteine-arginine-glutamic acid-lysine-alanine fibrin-homing peptide for glioblastoma therapy by enhanced retention effect.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@ast
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@en
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@nl
type
label
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@ast
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@en
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@nl
prefLabel
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@ast
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@en
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@nl
P2093
P2860
P356
P1476
Polyethylene glycol-polylactic ...... by enhanced retention effect.
@en
P2093
Jingjing Zhao
Xinguo Jiang
Zhiqing Pang
P2860
P304
P356
10.2147/IJN.S72649
P407
P577
2014-11-13T00:00:00Z